five

Available datapackage for study 'A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients With Unresectable Stage IV Urothelial Cancer'

收藏
DataCite Commons2025-05-27 更新2026-05-07 收录
下载链接:
https://search.vivli.org/doiLanding/dataPackages/PR00011394.0
下载链接
链接失效反馈
官方服务:
资源简介:
A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients With Unresectable Stage IV Urothelial Cancer
提供机构:
Vivli
创建时间:
2025-05-27
二维码
社区交流群
二维码
科研交流群
商业服务